As of August 2026, 6 paid clinical trials are recruiting in Shelton, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Shelton offers studies at sites including Providence Regional Cancer System-Shelton for conditions such as Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Elevated CA15-3 or CEA or CA27-29. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Shelton, WA at 2 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Providence Regional Cancer System-Shelton | Acral Lentiginous Melanoma, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8 | 5 |
| South Puget Intertribal Planning Agency (SPIPA) | Lung Carcinoma | 1 |
Recruiting trials in Shelton grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 6 recruiting clinical trials in Shelton, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Shelton compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Shelton include Acral Lentiginous Melanoma (1), Anatomic Stage IV Breast Cancer AJCC v8 (1), Clinical Stage IV Cutaneous Melanoma AJCC v8 (1), Elevated CA15-3 or CEA or CA27-29 (1), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Shelton on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Shelton include Providence Regional Cancer System-Shelton, South Puget Intertribal Planning Agency (SPIPA), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Shelton are Cancer & tumors (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.